Evaluation of the therapeutic efficacy of praziquantel against schistosomes in seven countries with ongoing large-scale deworming programs

The World Health Organization (WHO) recommends periodic assessment of the therapeutic efficacy of praziquantel (PZQ) to detect reduced efficacy that may arise from drug resistance in schistosomes. In this multi-country study (2014), we assessed the therapeutic efficacy of a single oral dose of PZQ (...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Parasitol Drugs Drug Resist
Main Authors: Levecke, B., Vlaminck, J., Andriamaro, L., Ame, S., Belizario, V., Degarege, A., Engels, D., Erko, B., Garba, A.D., Kaatano, G.M., Mekonnen, Z., Montresor, A., Olliaro, P., Pieri, O.S., Sacko, M., Sam-Wobo, S.O., Tchuem Tchuenté, L.A., Webster, J.P., Vercruysse, J.
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7595844/
https://ncbi.nlm.nih.gov/pubmed/33125936
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijpddr.2020.10.003
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados